Gibraltar Industries, Inc.
ROCKGibraltar Industries, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved −25.3% in a year while annual EPS moved −133.2% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is between stages. Underneath, the last four quarters read deteriorating — profit −150.0% year on year, and 170% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Gibraltar Industries, Inc. trades at $48.1, between stages. That is +2.5% against its own 200-day average. It sits at 39% of a 52-week range of $35 to $68. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 4 straight weeks.
Today the stock is between stages. At $48.1 it trades +2.5% versus its 200-day average and sits at 39% of its 52-week range ($35–$68).
Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved −25% while the S&P 500 moved +24% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 4 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Gibraltar Industries, Inc. trades at 22.9× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 22.9× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −133.2% against a −25.3% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Gibraltar Industries, Inc. reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −53.8% latest against +37.5% at its 12-quarter best), ROCE slipping at 5.2%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +11.8% | −6.4% | — | — |
| Profit | −28.6% | +7.7% | — | — |
| Stock price | −25.3% | — | — | — |
4-Factor Sector Score
36.5/100 — rank 23 of 29 in Building Products & Equipment · 75% evidence confidence
Gibraltar Industries, Inc. scores 36.5 out of 100 against the 29 companies it is compared with in Building Products & Equipment, ranking 23. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 12.3 + 6.8 + 11.7 + 5.7 = 36.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Gibraltar Industries, Inc. reported $0.4 B of revenue in the Mar 26 quarter, +44.0% year on year. That is the 4th straight quarter of year-on-year growth. Over 4 years it has compounded at −4.0% a year. The last full year, FY25, came in at $1.1 B. The last four reported quarters add to $1.3 B.
FY25 revenue came in at $1.1 B (+11.8% on the year), capping 4 years at −4.0% compound. The latest quarter (Mar 26) printed $0.4 B, +44.0% year on year — the 4th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +21.7% growth against the decade's −4.0% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +21.4% over the last 4 quarters against −4.5%/yr over the last 8 — accelerating; TTM profit −53.8% vs −26.1%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Gibraltar Industries, Inc.'s operating margin is 0.0% in the Mar 26 quarter, −12.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 7.5% to 13.7%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 0.0%, −12.0 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 7.5%–13.7%.
🚨 Why the margin moved: operating margin went −12.0 pp year on year while gross margin went −5.8 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Gibraltar Industries, Inc. posted a net loss of $0.01 B in the Mar 26 quarter. Full-year FY25 profit was $0.1 B. The 4-year compound rate is 9.3%. That loss is 2.8% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.0 B, −150.0% year on year. On the full year, FY25 printed $0.1 B (−28.6%), and the 4-year compound rate is 9.3%.
🚨 Why profit moved: revenue contributed +44.0% and the margin −12.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −57.5% vs revenue +21.7%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 170% of Gibraltar Industries, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.2 B of operating cash against $0.1 B of profit. After $0.1 B of capital spending, $0.1 B was left as free cash.
FY25: operating cash of $0.2 B against reported profit of $0.1 B, leaving free cash of $0.1 B after $0.1 B of capital spending. Across the last 3 fiscal years the conversion rate is 170% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Gibraltar Industries, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Gibraltar Industries, Inc. earns a ROE of 11% in FY25. That is up from a trough of 8% in FY21. Return on invested capital clears the cost of that capital by +0.7 percentage points, so growth here adds value rather than only size. The wiring behind it is 8.8% net margin on 0.82× asset turns.
FY25 ROE is 11%, recovered from a FY21 trough of 8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 8.8% net margin × 0.82× asset turns × 1.46× balance-sheet leverage ≈ 10.5% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 6.6% − 5.9% = a +0.7 pp spread. The 5.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Dividend
Gibraltar Industries, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Gibraltar Industries, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Gibraltar Industries, Inc. carries total debt of $1.4 B against shareholder equity of $0.9 B as of Mar 26, a debt-to-equity of 1.56. On the annual view that ratio went from 0.05 in FY21 to 0.05 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $1.4 B against shareholder equity of $0.9 B — a debt-to-equity of 1.56. On the annual view, debt-to-equity went from 0.05 (FY21) to 0.05 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
4.7% of Gibraltar Industries, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 3.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 4.7% of the float is sold short, and at typical trading volumes it would take about 3.8 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Gibraltar Industries, Inc.: the Z-score reads 1.60. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 1.60 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 1.60.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Masco CorporationMAS | 64.4/100Thin evidence · provisional58% evidence | FADING | 21.6/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence | 17.8/25 ROCE 12.6% · OPM 16.5% 76% evidence | 11.0/20 P/E 18.7× · PEG — 15% evidence | 14.0/20 RS sector 5.3% · RS bench -0.2% · 1Y 11.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 17.8 + 11 + 14 = 64.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Carlisle Companies IncorporatedCSL | 61.8/100Thin evidence · provisional58% evidence | TURNING | 20.1/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 15.6/25 ROCE 6.9% · OPM 17.1% 76% evidence | 10.6/20 P/E 20.8× · PEG — 15% evidence | 15.5/20 RS sector 4.5% · RS bench -0.9% · 1Y 5.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 15.6 + 10.6 + 15.5 = 61.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Apogee Enterprises, Inc.APOG | 59.1/100Mixed-positive evidence71% evidence | TURNING | 20.8/35 Revenue 1.8% · PAT 37.3% · OPM change 3.5 pp 71% evidence | 9.3/25 ROCE 2.1% · OPM 5.5% 76% evidence | 15.8/20 P/E 12× · PEG 0.33 65% evidence | 13.2/20 RS sector 4% · RS bench -1.6% · 1Y 2.4%7 of 12 weeks ahead 70% evidence |
| Exact sum: 20.8 + 9.3 + 15.8 + 13.2 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Trex Company, Inc.TREX | 57.8/100Mixed-positive evidence81% evidence | BREAKING OUT | 18.0/35 Revenue 5.3% · PAT -3.5% · OPM change 0.3 pp 83% evidence | 16.4/25 ROCE 7.6% · OPM 24.3% 76% evidence | 9.2/20 P/E 20.3× · PEG 1.98 65% evidence | 14.2/20 RS sector 2.5% · RS bench -3.8% · 1Y -21.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 16.4 + 9.2 + 14.2 = 57.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Johnson Controls International plcJCI | 57.1/100Thin evidence · provisional58% evidence | TURNING | 18.0/35 Revenue — · PAT — · OPM change -2.1 pp 45% evidence | 13.4/25 ROCE 3.4% · OPM 60.6% 76% evidence | 10.3/20 P/E 25.4× · PEG — 15% evidence | 15.4/20 RS sector 13.9% · RS bench 8.9% · 1Y 45.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 13.4 + 10.3 + 15.4 = 57.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Arlo Technologies, Inc.ARLO | 54.6/100Thin evidence · provisional58% evidence | BASING | 23.2/35 Revenue 10.7% · PAT — · OPM change 6.2 pp 62% evidence | 9.4/25 ROCE 5% · OPM 5% 76% evidence | 9.5/20 P/E 47.8× · PEG — 15% evidence | 12.5/20 RS sector 3.4% · RS bench -2.4% · 1Y -4.7%1 of 12 weeks ahead 70% evidence |
| Exact sum: 23.2 + 9.4 + 9.5 + 12.5 = 54.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Griffon CorporationGFF | 54.1/100Mixed-positive evidence81% evidence | FADING | 14.0/35 Revenue -0.8% · PAT -71.7% · OPM change -0.6 pp 83% evidence | 13.5/25 ROCE 4.8% · OPM 20.7% 76% evidence | 12.6/20 P/E 559.1× · PEG 0.54 65% evidence | 14.0/20 RS sector 8.7% · RS bench 3.4% · 1Y 34.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 14 + 13.5 + 12.6 + 14 = 54.1 · Decision use: Price leads the evidence: RS versus the benchmark is 3.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Armstrong World Industries, Inc.AWI | 53.5/100Thin evidence · provisional58% evidence | TURNING | 17.7/35 Revenue — · PAT — · OPM change -2.7 pp 45% evidence | 16.6/25 ROCE 8% · OPM 23% 76% evidence | 10.5/20 P/E 22× · PEG — 15% evidence | 8.7/20 RS sector -3.8% · RS bench -9% · 1Y -2.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 16.6 + 10.5 + 8.7 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Trane Technologies plcTT | 51.7/100Thin evidence · provisional58% evidence | BASING | 17.0/35 Revenue — · PAT — · OPM change -1.9 pp 45% evidence | 16.0/25 ROCE 8.2% · OPM 15.6% 76% evidence | 9.7/20 P/E 37.2× · PEG — 15% evidence | 9.0/20 RS sector 2.3% · RS bench -2.6% · 1Y 9.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 16 + 9.7 + 9 = 51.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Fortune Brands Innovations, Inc.FBIN | 49.6/100Mixed-negative evidence81% evidence | BREAKING OUT | 12.7/35 Revenue -2% · PAT -36.5% · OPM change -3.4 pp 83% evidence | 9.8/25 ROCE 1.1% · OPM 6% 76% evidence | 13.6/20 P/E 17× · PEG 0.93 65% evidence | 13.5/20 RS sector 1.6% · RS bench -4.2% · 1Y -5.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 9.8 + 13.6 + 13.5 = 49.6 · Decision use: Price leads the evidence: RS versus the benchmark is -4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11SPX Technologies, Inc.SPXC | 49.3/100Thin evidence · provisional58% evidence | TURNING | 20.5/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence | 13.4/25 ROCE 3.7% · OPM 15.5% 76% evidence | 9.6/20 P/E 41.6× · PEG — 15% evidence | 5.8/20 RS sector -2.7% · RS bench -7.3% · 1Y 7.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 13.4 + 9.6 + 5.8 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12NPK International Inc.NPKI | 48.3/100Thin evidence · provisional52% evidence | ASLEEP | 18.4/35 Revenue — · PAT — · OPM change -1.7 pp 45% evidence | 12.4/25 ROCE 4.3% · OPM 19.2% 76% evidence | 9.9/20 P/E 31.8× · PEG — 15% evidence | 7.6/20 RS sector -3.3% · RS bench -7.5% · 1Y 46.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.4 + 12.4 + 9.9 + 7.6 = 48.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13AirJoule Technologies CorporationAIRJ | 46.1/100Thin evidence · provisional52% evidence | LEADER | 12.0/35 Revenue — · PAT -249% · OPM change — 57% evidence | 5.7/25 ROCE -1.1% · OPM — 61% evidence | 11.4/20 P/E 8.7× · PEG — 15% evidence | 17.0/20 RS sector 37.7% · RS bench 30% · 1Y 30.4%12 of 12 weeks ahead 70% evidence |
| Exact sum: 12 + 5.7 + 11.4 + 17 = 46.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Lennox International Inc.LII | 44.4/100Thin evidence · provisional58% evidence | ASLEEP | 15.3/35 Revenue — · PAT — · OPM change -1.3 pp 45% evidence | 17.7/25 ROCE 13.3% · OPM 14.4% 76% evidence | 10.2/20 P/E 25.9× · PEG — 15% evidence | 1.2/20 RS sector -18% · RS bench -22.3% · 1Y -23.3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 17.7 + 10.2 + 1.2 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Owens CorningOC | 44.0/100Mixed-negative evidence64% evidence | BREAKING OUT | 9.1/35 Revenue -5.1% · PAT -308.2% · OPM change -10.8 pp 62% evidence | 7.0/25 ROCE 1.1% · OPM 5.3% 76% evidence | 9.8/20 P/E 35.7× · PEG — 15% evidence | 18.1/20 RS sector 9.4% · RS bench 3.3% · 1Y 1.1%8 of 12 weeks ahead 100% evidence |
| Exact sum: 9.1 + 7 + 9.8 + 18.1 = 44 · Decision use: Price leads the evidence: RS versus the benchmark is 3.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16AAON, Inc.AAON | 43.9/100Mixed-negative evidence81% evidence | ASLEEP | 22.9/35 Revenue 28.2% · PAT -25.8% · OPM change 0.6 pp 83% evidence | 13.4/25 ROCE 4.5% · OPM 11.5% 76% evidence | 4.6/20 P/E 57.9× · PEG 4.21 65% evidence | 3.0/20 RS sector -8.3% · RS bench -12.5% · 1Y 18.7%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 13.4 + 4.6 + 3 = 43.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.3% and the one-year return is 18.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 17Carrier Global CorporationCARR | 43.8/100Thin evidence · provisional58% evidence | ASLEEP | 15.8/35 Revenue — · PAT — · OPM change -7.3 pp 45% evidence | 9.8/25 ROCE 2.6% · OPM 4.8% 76% evidence | 9.4/20 P/E 50.9× · PEG — 15% evidence | 8.8/20 RS sector 1.4% · RS bench -3.7% · 1Y -0.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 9.8 + 9.4 + 8.8 = 43.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Quanex Building Products CorporationNX | 43.4/100Mixed-negative evidence69% evidence | BASING | 10.3/35 Revenue 14.3% · PAT -8166.7% · OPM change -5 pp 95% evidence | 6.5/25 ROCE 1% · OPM 4% 76% evidence | 10.1/20 P/E 27.9× · PEG — 15% evidence | 16.5/20 RS sector 14% · RS bench 8.1% · 1Y 6.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 10.3 + 6.5 + 10.1 + 16.5 = 43.4 · Decision use: Price leads the evidence: RS versus the benchmark is 8.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 19Limbach Holdings, Inc.LMB | 42.3/100Mixed-negative evidence81% evidence | TURNING | 15.5/35 Revenue 22.5% · PAT 0% · OPM change -5.1 pp 83% evidence | 7.3/25 ROCE 0.5% · OPM 0.8% 76% evidence | 12.1/20 P/E 28.4× · PEG 0.94 65% evidence | 7.4/20 RS sector -13.8% · RS bench -18.9% · 1Y -32.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 7.3 + 12.1 + 7.4 = 42.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Aspen Aerogels, Inc.ASPN | 41.1/100Thin evidence · provisional58% evidence | ASLEEP | 20.0/35 Revenue -47.4% · PAT — · OPM change 325.2 pp 62% evidence | 3.0/25 ROCE -5.2% · OPM -55% 76% evidence | 8.9/20 P/E 69.9× · PEG — 15% evidence | 9.2/20 RS sector -0.3% · RS bench -6.8% · 1Y -33%10 of 12 weeks ahead 70% evidence |
| Exact sum: 20 + 3 + 8.9 + 9.2 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Perma-Pipe International Holdings, Inc.PPIH | 39.8/100Mixed-negative evidence79% evidence | BASING | 15.6/35 Revenue 24.4% · PAT 5.9% · OPM change -7.7 pp 95% evidence | 10.7/25 ROCE 3.4% · OPM 9.2% 76% evidence | 8.8/20 P/E 19.3× · PEG 2 65% evidence | 4.7/20 RS sector -16.2% · RS bench -20.3% · 1Y -2.2%0 of 12 weeks ahead 70% evidence |
| Exact sum: 15.6 + 10.7 + 8.8 + 4.7 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Janus International Group, Inc.JBI | 38.6/100Thin evidence · provisional58% evidence | TURNING | 13.3/35 Revenue — · PAT — · OPM change -9.9 pp 45% evidence | 8.3/25 ROCE 1.1% · OPM 5.9% 76% evidence | 11.2/20 P/E 15.9× · PEG — 15% evidence | 5.8/20 RS sector -21.4% · RS bench -26.7% · 1Y -42.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 8.3 + 11.2 + 5.8 = 38.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Gibraltar Industries, Inc.this pageROCK | 36.5/100Mixed-negative evidence75% evidence | TURNING | 12.3/35 Revenue 21.1% · PAT -54.1% · OPM change -12.9 pp 83% evidence | 6.8/25 ROCE -0.3% · OPM -1.3% 76% evidence | 11.7/20 P/E 314× · PEG 0.92 65% evidence | 5.7/20 RS sector -8.4% · RS bench -14% · 1Y -17.4%2 of 12 weeks ahead 70% evidence |
| Exact sum: 12.3 + 6.8 + 11.7 + 5.7 = 36.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24JELD-WEN Holding, Inc.JELD | 35.9/100Thin evidence · provisional58% evidence | 20.1/35 Revenue -12.1% · PAT — · OPM change 16.2 pp 62% evidence | 3.5/25 ROCE -3.3% · OPM -7.6% 76% evidence | 9.3/20 P/E 57.4× · PEG — 15% evidence | 3.0/20 RS sector -58.7% · RS bench -62.8% · 1Y -77.3%4 of 10 weeks ahead 70% evidence | |
| Exact sum: 20.1 + 3.5 + 9.3 + 3 = 35.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Builders FirstSource, Inc.BLDR | 35.5/100Thin evidence · provisional58% evidence | BASING | 14.1/35 Revenue — · PAT — · OPM change -4.5 pp 45% evidence | 8.5/25 ROCE 1.3% · OPM 0.5% 76% evidence | 8.7/20 P/E 98.3× · PEG — 15% evidence | 4.2/20 RS sector -29.7% · RS bench -34.2% · 1Y -43%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 8.5 + 8.7 + 4.2 = 35.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Louisiana-Pacific CorporationLPX | 34.8/100Adverse evidence81% evidence | BASING | 6.0/35 Revenue -13% · PAT -79% · OPM change -10.7 pp 83% evidence | 8.8/25 ROCE 1.5% · OPM 5.9% 76% evidence | 14.0/20 P/E 62.2× · PEG 0.28 65% evidence | 6.0/20 RS sector -11.4% · RS bench -16.3% · 1Y -15.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 6 + 8.8 + 14 + 6 = 34.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 27Latham Group, Inc.SWIM | 33.9/100Adverse evidence64% evidence | BASING | 16.1/35 Revenue 8.7% · PAT — · OPM change -1.2 pp 62% evidence | 4.3/25 ROCE -0.9% · OPM -5.6% 76% evidence | 8.8/20 P/E 75.6× · PEG — 15% evidence | 4.7/20 RS sector -16.6% · RS bench -21.4% · 1Y -22.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 4.3 + 8.8 + 4.7 = 33.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Advanced Drainage Systems, Inc.WMS | 33.7/100Adverse evidence81% evidence | TURNING | 12.3/35 Revenue 5% · PAT -5.4% · OPM change -11.1 pp 83% evidence | 10.9/25 ROCE 1.5% · OPM 7.9% 76% evidence | 5.4/20 P/E 25.2× · PEG 4.38 65% evidence | 5.1/20 RS sector -3.7% · RS bench -8.5% · 1Y 14%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.3 + 10.9 + 5.4 + 5.1 = 33.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Madison Air Solutions CorporationMAIR | 54.8/100Thin evidence · provisional27% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change -1.4 pp 13% evidence | 15.0/25 ROCE 5.1% · OPM 16.4% 76% evidence | 11.5/20 P/E 0× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 4 weeks ahead 0% evidence |
| Exact sum: 18.3 + 15 + 11.5 + 10 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Gibraltar Industries, Inc.'s stock price today?
Gibraltar Industries, Inc. trades at $48.1, −25.3% over the past year. The company is valued at $1.0 B. The stock sits at 39% of its 52-week range of $35–$68, +2.5% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 4 weeks. — as of 5 August 2026.
What were Gibraltar Industries, Inc.'s latest quarterly results?
Gibraltar Industries, Inc. reported revenue of $0.4 B and a net loss of $0.0 B for the Mar 26 quarter. Revenue rose 44.0% and profit fell 150.0% year on year. Earnings per share were $−2.26. The operating margin was 0.0%, 12.0 pp lower than a year earlier. — as of 5 August 2026.
What is Gibraltar Industries, Inc.'s revenue?
Gibraltar Industries, Inc. reported revenue of $0.4 B in the Mar 26 quarter, +44.0% year on year. For the full FY25 fiscal year, revenue was $1.1 B (+11.8%). Over the last 4 years revenue compounded at −4.0% a year. — as of 5 August 2026.
What is Gibraltar Industries, Inc.'s profit?
Gibraltar Industries, Inc. earned $−0.0 B of net profit in the Mar 26 quarter, −150.0% year on year. Full-year FY25 profit was $0.1 B. The operating margin ran 0.0% in the latest quarter. — as of 5 August 2026.
What is Gibraltar Industries, Inc.'s market cap?
Gibraltar Industries, Inc.'s market capitalisation is $1.0 B at a stock price of $48.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Gibraltar Industries, Inc. pay a dividend?
No — Gibraltar Industries, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Gibraltar Industries, Inc. growing?
Not right now — Gibraltar Industries, Inc.'s latest numbers are shrinking: latest-quarter revenue +44.0% year on year, profit −150.0%, and the margin −12.0 pp at 0.0%. The 4-year compound rates are −4.0% (revenue) and 9.3% (profit). The earnings engine currently reads: deteriorating — as of 5 August 2026.
How is Gibraltar Industries, Inc. performing?
Gibraltar Industries, Inc.'s latest readings are below. Its latest quarter's revenue rose 44.0% and profit fell 150.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Gibraltar Industries, Inc. in?
Deteriorating — profit and EPS growth are shrinking (profit growth −53.8% latest against +37.5% at its 12-quarter best), ROCE slipping at 5.2%. The read comes from the last 12 quarters of growth (revenue growth +21.4% latest, profit growth −53.8% latest, eps growth −200.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Gibraltar Industries, Inc. beating the market?
On recent form, yes — Gibraltar Industries, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 4 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved −25% against the S&P 500's +24% — behind the index over the full window. — as of 5 August 2026.
Will Gibraltar Industries, Inc.'s stock price go up?
This page publishes no price forecast for Gibraltar Industries, Inc. What it measures instead: the stock price is $48.1. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Gibraltar Industries, Inc.?
Somewhat — short interest is 4.7% of Gibraltar Industries, Inc.'s tradable float, about 3.8 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Gibraltar Industries, Inc. have too much debt?
It carries real leverage — Gibraltar Industries, Inc.'s debt-to-equity is 1.56. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Gibraltar Industries, Inc.'s capex?
Gibraltar Industries, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.1 B. — as of 5 August 2026.
What is Gibraltar Industries, Inc.'s cash flow?
Gibraltar Industries, Inc. generated $0.2 B of operating cash flow in FY25 and $0.1 B of free cash flow after $0.1 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Gibraltar Industries, Inc.'s profit real cash?
Yes — over the last 3 fiscal years, 170% of Gibraltar Industries, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.2 B against reported profit of $0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Gibraltar Industries, Inc.?
On the balance sheet, the Z-score reads 1.60 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is Gibraltar Industries, Inc. in its business cycle?
Gibraltar Industries, Inc.'s FY25 operating margin was 10.5%, against a 5-year band of 7.5%–13.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Gibraltar Industries, Inc. story?
The sharpest disagreement: the price moved −25.3% in a year while annual EPS moved −133.2% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Gibraltar Industries, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Gibraltar Industries, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.